Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 24
Filter
Add more filters










Publication year range
1.
Sci Rep ; 14(1): 2689, 2024 02 01.
Article in English | MEDLINE | ID: mdl-38302481

ABSTRACT

Hepatic and pulmonary lesions are common in cetaceans, despite their poorly understood viral etiology. Herpesviruses (HV), adenoviruses (AdV) and hepatitis E virus (HEV) are emerging agents in cetaceans, associated with liver and/or pulmonary damage in mammals. We isolated and molecularly tested DNA for HV and AdV (n = 218 individuals; 187 liver and 108 lung samples) and RNA for HEV (n = 147 animals; 147 liver samples) from six cetacean families. All animals stranded or were bycaught in Brazil between 2001 and 2021. Positive-animals were analyzed by histopathology. Statistical analyses assessed if the prevalence of viral infection could be associated with the variables: species, family, habitat, region, sex, and age group. All samples were negative for AdV and HEV. Overall, 8.7% (19/218) of the cetaceans were HV-positive (4.8% [9/187] liver and 11.1% [12/108] lung), without HV-associated lesions. HV-prevalence was statistically significant higher in Pontoporiidae (19.2%, 10/52) when compared to Delphinidae (4.1%, 5/121), and in southeastern (17.1%, 13/76)-the most industrialized Brazilian region-when compared to the northeastern region (2.4%, 3/126). This study broadens the herpesvirus host range in cetaceans, including its description in pygmy sperm whales (Kogia breviceps) and humpback whales (Megaptera novaeangliae). Further studies must elucidate herpesvirus drivers in cetaceans.


Subject(s)
Adenoviridae Infections , Hepatitis E virus , Herpesviridae , Humpback Whale , Humans , Animals , Brazil/epidemiology , Adenoviridae/genetics , Herpesviridae/genetics , Adenoviridae Infections/epidemiology , Adenoviridae Infections/veterinary , Liver , Lung
2.
Sci Rep ; 11(1): 23618, 2021 12 08.
Article in English | MEDLINE | ID: mdl-34880273

ABSTRACT

Humpback whales (Megaptera novaeangliae) are a cosmopolitan species and perform long annual migrations between low-latitude breeding areas and high-latitude feeding areas. Their breeding populations appear to be spatially and genetically segregated due to long-term, maternally inherited fidelity to natal breeding areas. In the Southern Hemisphere, some humpback whale breeding populations mix in Southern Ocean waters in summer, but very little movement between Pacific and Atlantic waters has been identified to date, suggesting these waters constituted an oceanic boundary between genetically distinct populations. Here, we present new evidence of summer co-occurrence in the West Antarctic Peninsula feeding area of two recovering humpback whale breeding populations from the Atlantic (Brazil) and Pacific (Central and South America). As humpback whale populations recover, observations like this point to the need to revise our perceptions of boundaries between stocks, particularly on high latitude feeding grounds. We suggest that this "Southern Ocean Exchange" may become more frequent as populations recover from commercial whaling and climate change modifies environmental dynamics and humpback whale prey availability.


Subject(s)
Humpback Whale/physiology , Reproduction , Animal Migration , Animals , Climate Change , Feeding Behavior , Oceans and Seas
3.
Placenta ; 32(11): 859-64, 2011 Nov.
Article in English | MEDLINE | ID: mdl-21903263

ABSTRACT

Placental dysfunction leads to foetal damage, which jeopardises the exchange between the maternal and foetal systems. We evaluated the effects of tumour growth on the activity of antioxidant enzymes and oxidative stress in placental tissue and cell culture from tumour-bearing pregnant rats compared to non-tumour-bearing pregnant rats that were ascitic fluid injected. Ascitic fluid is obtained from Walker tumour-bearing rats and contains a cytokine called Walker factor (WF), which is a molecule similar to proteolysis-inducing factor (PIF), and induces changes in protein metabolism and oxidative stress. Pregnant Wistar rats were distributed into control (C), tumour-bearing (W) and ascitic fluid injected (A) groups and were sacrificed on days 16, 19 and 21 of pregnancy to analyse the profile of enzyme activities (glutathione-S-transferase (GST), catalase (CAT), alkaline phosphatase (AP)) and malondialdehyde (MDA) content in placental tissue. Meanwhile, placenta samples from all groups were obtained on day 21, placed in primary culture and treated with WF for 72 h. The presence of tumour or ascitic fluid reduced the protein content of the placental tissue. On day 16 there was a significant reduction in AP activity in W rats, and on day 19, CAT activity and MDA content significantly increased. These results indicate that the presence of cancer decreased antioxidant enzyme capacity in the placenta, increasing the amount of oxidation in these cells, which may contribute to irreversible placental damage and compromisefoetal development. WF treatment induces similar changes in placental cells in primary culture, resulting in less cell viability and increased oxidative stress. These results indicate that WF, provided by the tumour or inoculation of ascitic fluid, has negative effects on placental homeostasis, which impairs foetal health.


Subject(s)
Oxidative Stress/physiology , Placenta/metabolism , Placenta/pathology , Pregnancy Complications, Neoplastic/pathology , Animals , Antioxidants/metabolism , Carcinoma 256, Walker/metabolism , Carcinoma 256, Walker/pathology , Catalase/metabolism , Cells, Cultured , Female , Malondialdehyde/metabolism , Placenta/cytology , Pregnancy , Pregnancy Complications, Neoplastic/metabolism , Primary Cell Culture , Rats , Rats, Wistar , Tumor Cells, Cultured , Up-Regulation
4.
Endocr Relat Cancer ; 11(4): 887-95, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15613461

ABSTRACT

Leucine can modulate skeletal muscle metabolism by enhancing protein synthesis and decreasing proteolysis. In this study, we investigated the effects of leucine on the ubiquitin-proteasome system in skeletal muscle of pregnant tumour-bearing rats fed a leucine-rich diet. Pregnant Wistar rats were distributed into three groups that were fed a semi-purified control diet (C, control; W, Walker tumour-bearing; P, pair-fed) and three other groups of pregnant rats fed a semi-purified leucine-rich diet (L, leucine; WL, Walker tumour-bearing; PL, pair-fed). The tumour-bearing rats were injected subcutaneously with a suspension of Walker 256 tumour cells. Protein synthesis and degradation were measured in gastrocnemius muscle; the total protein content and tissue chymotrypsin-like and alkaline phosphatase enzyme activities were also determined. Muscle protein extracts were run on SDS-PAGE to assess the expression of the myosin heavy chain (MHC), 20S alpha proteasome subunit, 19S MSSI ATPase regulator subunit and 11S alpha subunit. Although tumour growth decreased the incorporation of [3H]-Phe, the concomitant feeding of a leucine-rich diet increased the rate of protein synthesis. Muscle proteolysis in both tumour-bearing groups was increased more than in the respective control groups. Conversely, the leucine-rich diet caused less protein breakdown in the WL group than in the W group. Only the W group showed a significant reduction (71%) in the myosin content. In WL rats, the 20S proteasome content (32 kDa band) was reduced, while the expression of the 19S subunit was 3-fold less than in the W group and the 11S proteasome subunit reduced, to around 32% less than in the W group. These findings clearly indicate that leucine can stimulate protein synthesis and inhibit protein breakdown in pregnant rats, probably by modulating the activation of the ubiquitin-proteasome system during tumour growth.


Subject(s)
Carcinoma 256, Walker/metabolism , Dietary Supplements , Leucine/administration & dosage , Muscle, Skeletal/metabolism , Pregnancy Complications, Neoplastic/metabolism , Proteasome Endopeptidase Complex/metabolism , Animals , Electrophoresis, Polyacrylamide Gel , Female , Myosin Heavy Chains/metabolism , Phenylalanine/metabolism , Pregnancy , Protein Biosynthesis , Rats , Rats, Wistar , Tumor Cells, Cultured , Tyrosine/metabolism , Ubiquitin/metabolism
5.
Placenta ; 25(5): 456-62, 2004 May.
Article in English | MEDLINE | ID: mdl-15081640

ABSTRACT

The placenta provides all energy and nutrient requirements for healthy fetal development. The placenta in rats is capable of storing glycogen, although the placenta cells must therefore mobilize stored glycogen to its own glucose supply. Moreover, maternal glucose and/or placental lactate furnished the fetal growth. Adult female Wistar rats were divided into three groups: Control-C, tumour bearing-W; injected ascitic fluid-A. The rats were sacrificed on the 16th, 19th or 21st day of gestation, analysing the placenta and fetus weights and placental tissue samples was aliquoted for biochemical assays of glycogen and protein content and alkaline phosphatase activity. Placental sections were morphometrically analysed and glycogen positive cells were counted. The placental and fetal weight were significantly reduced in both W and A rats from 16th up to 21st day of gestation, which showed high levels of fetal reabsorption sites. Significant reduction in labyrinth zone at day 21 in both tumour bearing and ascitic fluid injected groups was shown, suggesting less substrate exchange at the maternal/fetal surface. The alkaline phosphatase activity as well total protein content were found to be reduced in W and A group. The total placental glycogen and glycogen cells decreased during tumour bearing and ascitic fluid injection, suggesting reduction in its own stored energy. Ascitic fluid injected group, representing an indirect tumour effect, presented similar reduction changes in the placenta to the tumour-bearing group. In conclusion, the tumour growth and, especially, ascitic fluid injection promoted irreversible placental tissue damage altering homeostasis and compromising fetal development.


Subject(s)
Carcinoma 256, Walker/metabolism , Glycogen/metabolism , Placenta/metabolism , Alkaline Phosphatase/metabolism , Animals , Carcinoma 256, Walker/complications , Carcinoma 256, Walker/pathology , Cell Count , Decidua/pathology , Female , Fetal Resorption , Fetal Weight , Glycogen/analysis , Organ Size , Placenta/pathology , Placenta/physiopathology , Pregnancy , Rats , Rats, Wistar , Trophoblasts/chemistry , Trophoblasts/pathology
6.
Braz. j. med. biol. res ; 36(11): 1589-1594, Nov. 2003. graf
Article in English | LILACS | ID: lil-348287

ABSTRACT

Cancer cachexia induces host protein wastage but the mechanisms are poorly understood. Branched-chain amino acids play a regulatory role in the modulation of both protein synthesis and degradation in host tissues. Leucine, an important amino acid in skeletal muscle, is higher oxidized in tumor-bearing animals. A leucine-supplemented diet was used to analyze the effects of Walker 256 tumor growth on body composition in young weanling Wistar rats divided into two main dietary groups: normal diet (N, 18 percent protein) and leucine-rich diet (L, 15 percent protein plus 3 percent leucine), which were further subdivided into control (N or L) or tumor-bearing (W or LW) subgroups. After 12 days, the animals were sacrificed and their carcass analyzed. The tumor-bearing groups showed a decrease in body weight and fat content. Lean carcass mass was lower in the W and LW groups (W = 19.9 ± 0.6, LW = 23.1 ± 1.0 g vs N = 29.4 ± 1.3, L = 28.1 ± 1.9 g, P < 0.05). Tumor weight was similar in both tumor-bearing groups fed either diet. Western blot analysis showed that myosin protein content in gastrocnemius muscle was reduced in tumor-bearing animals (W = 0.234 ± 0.033 vs LW = 0.598 ± 0.036, N = 0.623 ± 0.062, L = 0.697 ± 0.065 arbitrary intensity, P < 0.05). Despite accelerated tumor growth, LW animals exhibited a smaller reduction in lean carcass mass and muscle myosin maintenance, suggesting that excess leucine in the diet could counteract, at least in part, the high host protein wasting in weanling tumor-bearing rats.


Subject(s)
Animals , Male , Rats , Carcinoma 256, Walker , Dietary Supplements , Leucine , Muscle Proteins , Muscle, Skeletal , Body Composition , Body Weight , Cachexia , Leucine , Muscle Proteins , Muscle, Skeletal , Rats, Wistar
7.
Braz J Med Biol Res ; 36(11): 1589-94, 2003 Nov.
Article in English | MEDLINE | ID: mdl-14576914

ABSTRACT

Cancer cachexia induces host protein wastage but the mechanisms are poorly understood. Branched-chain amino acids play a regulatory role in the modulation of both protein synthesis and degradation in host tissues. Leucine, an important amino acid in skeletal muscle, is higher oxidized in tumor-bearing animals. A leucine-supplemented diet was used to analyze the effects of Walker 256 tumor growth on body composition in young weanling Wistar rats divided into two main dietary groups: normal diet (N, 18% protein) and leucine-rich diet (L, 15% protein plus 3% leucine), which were further subdivided into control (N or L) or tumor-bearing (W or LW) subgroups. After 12 days, the animals were sacrificed and their carcass analyzed. The tumor-bearing groups showed a decrease in body weight and fat content. Lean carcass mass was lower in the W and LW groups (W = 19.9 0.6, LW = 23.1 1.0 g vs N = 29.4 1.3, L = 28.1 1.9 g, P < 0.05). Tumor weight was similar in both tumor-bearing groups fed either diet. Western blot analysis showed that myosin protein content in gastrocnemius muscle was reduced in tumor-bearing animals (W = 0.234 0.033 vs LW = 0.598 0.036, N = 0.623 0.062, L = 0.697 0.065 arbitrary intensity, P < 0.05). Despite accelerated tumor growth, LW animals exhibited a smaller reduction in lean carcass mass and muscle myosin maintenance, suggesting that excess leucine in the diet could counteract, at least in part, the high host protein wasting in weanling tumor-bearing rats.


Subject(s)
Carcinoma 256, Walker/metabolism , Dietary Supplements , Leucine/administration & dosage , Muscle Proteins/metabolism , Muscle, Skeletal/chemistry , Animals , Body Composition , Body Weight , Cachexia/metabolism , Leucine/metabolism , Male , Rats , Rats, Wistar
8.
J Submicrosc Cytol Pathol ; 34(2): 227-31, 2002 Apr.
Article in English | MEDLINE | ID: mdl-12117285

ABSTRACT

We have described that administration of seeds or parts of the seed of Senna occidentalis (coffee senna) for long periods, induces histochemical changes in the skeletal muscles of hens and rats that are characteristic of a mitochondrial myopathy--as decrease of SDH and COX activity, with some COX negative fibers. In this experimental model of mitochondrial myopathy, as in many human mitochondrial diseases, there is a random distribution of COX negative fibers. Some fibers are completely COX negative while others are partially negative and others are completely positive. In the present work we have studied the distribution of COX negative mitochondria at transmission electron microscopy in skeletal muscle of rats in this experimental myopathy. In myofibers of intoxicated animals the expression of COX was heterogeneous. The histochemical reaction was observed in the internal membrane (more evident in mitochondrial cristae) of all mitochondria of some myofibers, while it was almost absent in other myofibers. In these myofibers the great part of the mitochondria were negative for COX reaction while other ones had a weak expression of this enzyme (dot or focal expression of COX). Our results indicated that the COX mitochondrial activity is heterogeneously impaired in myofibers of rats intoxicated with S. occidentalis. These abnormalities remember those observed in some types of human mitochondrial myopathies.


Subject(s)
Cytochrome-c Oxidase Deficiency , Mitochondria/drug effects , Muscle Fibers, Skeletal/drug effects , Muscle, Skeletal/drug effects , Seeds/toxicity , Senna Plant , Diet , Disease Models, Animal , Mitochondria/enzymology , Mitochondria/ultrastructure , Mitochondrial Myopathies/enzymology , Mitochondrial Myopathies/etiology , Mitochondrial Myopathies/pathology , Muscle Fibers, Skeletal/enzymology , Muscle Fibers, Skeletal/ultrastructure , Muscle, Skeletal/enzymology , Muscle, Skeletal/ultrastructure , Plants, Medicinal , Senna Extract/toxicity , Senna Plant/chemistry
9.
Br J Cancer ; 86(10): 1628-33, 2002 May 20.
Article in English | MEDLINE | ID: mdl-12085214

ABSTRACT

The mechanism of muscle protein catabolism induced by proteolysis-inducing factor, produced by cachexia-inducing murine and human tumours has been studied in vitro using C(2)C(12) myoblasts and myotubes. In both myoblasts and myotubes protein degradation was enhanced by proteolysis-inducing factor after 24 h incubation. In myoblasts this followed a bell-shaped dose-response curve with maximal effects at a proteolysis-inducing factor concentration between 2 and 4 nM, while in myotubes increased protein degradation was seen at all concentrations of proteolysis-inducing factor up to 10 nM, again with a maximum of 4 nM proteolysis-inducing factor. Protein degradation induced by proteolysis-inducing factor was completely attenuated in the presence of cycloheximide (1 microM), suggesting a requirement for new protein synthesis. In both myoblasts and myotubes protein degradation was accompanied by an increased expression of the alpha-type subunits of the 20S proteasome as well as functional activity of the proteasome, as determined by the 'chymotrypsin-like' enzyme activity. There was also an increased expression of the 19S regulatory complex as well as the ubiquitin-conjugating enzyme (E2(14k)), and in myotubes a decrease in myosin expression was seen with increasing concentrations of proteolysis-inducing factor. These results show that proteolysis-inducing factor co-ordinately upregulates both ubiquitin conjugation and proteasome activity in both myoblasts and myotubes and may play an important role in the muscle wasting seen in cancer cachexia.


Subject(s)
Blood Proteins/pharmacology , Muscle Proteins/metabolism , Adenosine Triphosphatases/biosynthesis , Adenosine Triphosphatases/genetics , Animals , Antibodies, Monoclonal/immunology , Cachexia/metabolism , Cells, Cultured/drug effects , Cells, Cultured/metabolism , Cysteine Endopeptidases/biosynthesis , Cysteine Endopeptidases/genetics , Cysteine Endopeptidases/metabolism , Dose-Response Relationship, Drug , Endopeptidases/biosynthesis , Endopeptidases/genetics , Gene Expression Regulation , Macromolecular Substances , Mice , Multienzyme Complexes/biosynthesis , Multienzyme Complexes/genetics , Multienzyme Complexes/metabolism , Muscle, Skeletal/cytology , Muscle, Skeletal/drug effects , Muscle, Skeletal/metabolism , Myosin Heavy Chains/immunology , Myosin Heavy Chains/metabolism , Proteasome Endopeptidase Complex , Protein Subunits , Proteoglycans , Ubiquitin/metabolism
10.
J Immunol ; 167(9): 5429-38, 2001 Nov 01.
Article in English | MEDLINE | ID: mdl-11673562

ABSTRACT

One of the consequences of HIV infection is damage to the CNS. To characterize the virologic, immunologic, and functional factors involved in HIV-induced CNS disease, we analyzed the viral loads and T cell infiltrates in the brains of SIV-infected rhesus monkeys whose CNS function (sensory evoked potential) was impaired. Following infection, CNS evoked potentials were abnormal, indicating early CNS disease. Upon autopsy at 11 wk post-SIV inoculation, the brains of infected animals contained over 5-fold more CD8(+) T cells than did uninfected controls. In both infected and uninfected groups, these CD8(+) T cells presented distinct levels of activation markers (CD11a and CD95) at different sites: brain > CSF > spleen = blood > lymph nodes. The CD8(+) cells obtained from the brains of infected monkeys expressed mRNA for cytolytic and proinflammatory molecules, such as granzymes A and B, perforin, and IFN-gamma. Therefore, the neurological dysfunctions correlated with increased numbers of CD8(+) T cells of an activated phenotype in the brain, suggesting that virus-host interactions contributed to the related CNS functional defects.


Subject(s)
AIDS Dementia Complex/etiology , Brain Diseases/etiology , Brain/immunology , CD8-Positive T-Lymphocytes/immunology , Lymphocyte Activation , Simian Acquired Immunodeficiency Syndrome/immunology , Animals , CD28 Antigens/analysis , Immunophenotyping , Lymphocyte Function-Associated Antigen-1/analysis , Macaca mulatta , Simian Acquired Immunodeficiency Syndrome/complications , fas Receptor/analysis
11.
J Immunol ; 167(6): 3074-81, 2001 Sep 15.
Article in English | MEDLINE | ID: mdl-11544291

ABSTRACT

It has become increasingly apparent in studies of mutant mice and observations of disease that cytokine production by fully committed effector T cells within the Th1 and Th2 phenotype can vary within each group. This can potentially influence the type and effectiveness of a given immune response. The factors responsible for inducing variable Th1 and Th2 subtype responses have not been well established. Using transgenic mice expressing the myelin basic protein-specific TCR, we demonstrate here that two distinct populations of Th2 cells that are characterized primarily by differential IL-4 and IL-5 expression levels can be generated depending upon the levels of IFN-gamma present at the time of priming. We also demonstrate that populations expressing high levels of IL-4 relative to IL-5 vs those with intermediate levels of IL-4 relative to IL-5 are stable and possess distinct effector functions in an experimental autoimmune encephalomyelitis model.


Subject(s)
Autoimmune Diseases/immunology , Autoimmunity/physiology , Encephalomyelitis, Autoimmune, Experimental/immunology , Interferon-gamma/physiology , Th2 Cells/immunology , Adoptive Transfer , Animals , Autoimmune Diseases/metabolism , Encephalomyelitis, Autoimmune, Experimental/metabolism , Gene Expression Profiling , Homeodomain Proteins/genetics , Homeodomain Proteins/physiology , Interferon-gamma/deficiency , Interferon-gamma/genetics , Interleukin-4/biosynthesis , Interleukin-4/genetics , Interleukin-4/physiology , Interleukin-5/biosynthesis , Interleukin-5/genetics , Interleukin-5/physiology , Lymphokines/analysis , Mice , Mice, Inbred C57BL , Mice, Knockout , Mice, Transgenic , Myelin Basic Protein/immunology , Phenotype , Receptors, Antigen, T-Cell, alpha-beta/deficiency , Receptors, Antigen, T-Cell, alpha-beta/genetics , Specific Pathogen-Free Organisms , Th1 Cells/immunology , Th2 Cells/metabolism , Th2 Cells/transplantation
12.
Braz J Med Biol Res ; 34(3): 333-8, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11262583

ABSTRACT

Cancer patients present high mobilization of host protein, with a decrease in lean body mass and body fat depletion occurring in parallel to neoplastic growth. Since leucine is one of the principal amino acids used by skeletal muscle for energy, we investigated the changes in body composition of pregnant tumor-bearing rats after a leucine-supplemented diet. Sixty pregnant Wistar rats divided into six groups were fed a normal protein diet (18%, N) or a leucine-supplemented diet (3% L-leucine, L). The pregnant groups were: control (CN), Walker 256 carcinoma-bearing rats (WN), control rats pair-fed with tumor-bearing rats (pfN), leucine-supplemented (CL), leucine-supplemented tumor-bearing (WL), and leucine-supplemented rats pair-fed with tumor-bearing rats (pfL). At the end of pregnancy, all animals were sacrificed and body weight and tumor and fetal weight were determined. The carcasses were then analyzed for water, fat and total, collagen and non-collagen nitrogen content. Carcass weight was reduced in the WN, WL, pfN and pfL groups compared to control. The lean body mass and total carcass nitrogen were reduced in both tumor-bearing groups. Despite tumor growth and a decrease in fetal weight, there was a slight decrease in collagen (7%) and non-collagen nitrogen (8%) in the WL group compared with the WN group which showed a decrease of 8 and 12%, respectively. Although the WL group presented severe tumor growth effects, total carcass nitrogen and non-collagen nitrogen were particularly higher in this leucine-supplemented group compared to the WN group. These data suggest that the leucine-supplemented diet had a beneficial effect, probably attenuating body wasting.


Subject(s)
Body Composition/drug effects , Cachexia/metabolism , Carcinoma 256, Walker/metabolism , Dietary Supplements , Leucine/metabolism , Animals , Body Composition/physiology , Body Weight/drug effects , Body Weight/physiology , Collagen/metabolism , Female , Fetal Weight/drug effects , Fetal Weight/physiology , Leucine/administration & dosage , Muscle, Skeletal/drug effects , Nitrogen/metabolism , Pregnancy , Rats , Rats, Wistar , Statistics, Nonparametric
13.
Braz. j. med. biol. res ; 34(3): 333-338, Mar. 2001. tab
Article in English | LILACS | ID: lil-281613

ABSTRACT

Cancer patients present high mobilization of host protein, with a decrease in lean body mass and body fat depletion occurring in parallel to neoplastic growth. Since leucine is one of the principal amino acids used by skeletal muscle for energy, we investigated the changes in body composition of pregnant tumor-bearing rats after a leucine-supplemented diet. Sixty pregnant Wistar rats divided into six groups were fed a normal protein diet (18 percent, N) or a leucine-supplemented diet (3 percent L-leucine, L). The pregnant groups were: control (CN), Walker 256 carcinoma-bearing rats (WN), control rats pair-fed with tumor-bearing rats (pfN), leucine-supplemented (CL), leucine-supplemented tumor-bearing (WL), and leucine-supplemented rats pair-fed with tumor-bearing rats (pfL). At the end of pregnancy, all animals were sacrificed and body weight and tumor and fetal weight were determined. The carcasses were then analyzed for water, fat and total, collagen and non-collagen nitrogen content. Carcass weight was reduced in the WN, WL, pfN and pfL groups compared to control. The lean body mass and total carcass nitrogen were reduced in both tumor-bearing groups. Despite tumor growth and a decrease in fetal weight, there was a slight decrease in collagen (7 percent) and non-collagen nitrogen (8 percent) in the WL group compared with the WN group which showed a decrease of 8 and 12 percent, respectively. Although the WL group presented severe tumor growth effects, total carcass nitrogen and non-collagen nitrogen were particularly higher in this leucine-supplemented group compared to the WN group. These data suggest that the leucine-supplemented diet had a beneficial effect, probably attenuating body wasting


Subject(s)
Animals , Female , Rats , Body Composition/drug effects , Carcinoma 256, Walker/metabolism , Dietary Supplements , Leucine/administration & dosage , Leucine/metabolism , Body Composition/physiology , Body Weight/drug effects , Body Weight/physiology , Cachexia , Collagen/metabolism , Muscle, Skeletal/drug effects , Nitrogen/metabolism , Rats, Wistar , Statistics, Nonparametric
14.
Microbes Infect ; 2(4): 347-52, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10817635

ABSTRACT

In the present work we show that acute infection of C3H mice with the CL strain of Trypanosoma cruzi is characterized by an exponential growth of parasites and high mortality accompanied by anemia, thrombocytopenia, leukopenia, and bone marrow hypoplasia. Administration of nifurtimox, a trypanocydal drug currently in clinical use at different days postinfection, modulates parasitemia and prevents mortality. More importantly, none of blood and bone marrow alterations were observed in nifurtimox-treated animals when treatment was initiated early in infection, one or seven days postinoculation. The bone marrow alterations were characterized by a decrease in the total number cells as well in the number of megakaryoblasts and erythroblasts. Transfer experiments of bone marrow cells from infected mice to noninfected lethally irradiated recipients revealed a poor marrow-repopulating activity. The colony forming units-spleen assay confirmed the depression of committed clonal progenitors cells and revealed a decreased number of granulocyte/macrophage, megacariocyte and erythrocyte colonies. In summary, this is the first report showing that acute T. cruzi infection results in profound alterations of the hematopoietic system and that these alterations can be prevented by nifurtimox treatment.


Subject(s)
Chagas Disease/complications , Chagas Disease/drug therapy , Nifurtimox/therapeutic use , Trypanocidal Agents/therapeutic use , Trypanosoma cruzi/drug effects , Anemia/etiology , Anemia/prevention & control , Animals , Blood Cell Count , Bone Marrow/pathology , Chagas Disease/blood , Chagas Disease/pathology , Female , Hematopoietic Stem Cells/drug effects , Hematopoietic Stem Cells/physiology , Leukopenia/etiology , Leukopenia/prevention & control , Mice , Mice, Inbred C3H , Parasitemia/drug therapy , Thrombocytopenia/etiology , Thrombocytopenia/prevention & control , Trypanosoma cruzi/growth & development
15.
Oncol Res ; 11(8): 359-66, 1999.
Article in English | MEDLINE | ID: mdl-10803739

ABSTRACT

In the present study we investigated the influence of Walker 256 tumor growth on the modification of placental morphology and on fetal development in young and adult pregnant rats. After mating, female rats were divided into six groups: young control pregnant (Y), young pregnant with tumor (Yw), young pregnant injected with ascitic fluid (Ya), adult control pregnant (A), adult pregnant with tumor (Aw), and adult pregnant injected with ascitic fluid (Aa). Rats from tumor-bearing groups (Yw and Aw) were injected with 2.5 x 10(6) viable tumor cells into the right flank. Rats from Ya and Aa groups received daily inoculations of ascitic fluid (2.0 ml, i.p.) obtained from tumor-bearing rats without tumor cells. After 21 days, all animals were killed and the placentas were weighed and fixed with paraformaldehyde for histological analysis. Compared with control groups (Y and A), both tumor-bearing groups (Yw and Aw) presented the following changes: i) hemorrhage in the decidua and in the trophoblast giant cell layer; ii) disarrangement of the spongy zone, iii) restricted delimitation of the maternal and fetal blood vessels in the placental labyrinth; iv) hemorrhage and edema in the placental labyrinth. Similar results were observed in the placenta of groups injected with ascitic fluid (Ya and Aa). These results indicate that tumor development during pregnancy can have deleterious effects on placenta and fetus. These observations extend our previous data of extensive fetal reabsorption in both pregnant tumor-bearing and ascitic fluid-injected animals. These changes in placental morphology may be related to the synthesis and release of some factors by the tumor and the host cells, which could act directly or indirectly on placental tissue.


Subject(s)
Carcinoma 256, Walker/pathology , Placenta/pathology , Pregnancy Complications, Neoplastic/pathology , Age Factors , Animals , Female , Litter Size , Organ Size , Placenta/anatomy & histology , Pregnancy , Rats , Rats, Wistar
16.
Braz. j. med. biol. res ; 31(10): 1345-8, Oct. 1998. tab, graf
Article in English | LILACS | ID: lil-223998

ABSTRACT

In tumor-bearing rats, most of the serum amino acids are used for synthesis and oxidation processes by the neoplastic tissue. In the present study, the effect of Walker 256 carcinoma growth on the intestinal absorption of leucine, methionine and glucose was investigated in newly weaned and mature rats. Food intake and carcass weight were decreased in newly weaned (NT) and mature (MT) rats bearing Walker 256 tumor in comparison with control animals (NC and MC). The tumor/carcass weight ratio was higher in NT than in MT rats, whereas nitrogen balance was significantly decreased in both as compared to control animals. Glucose absorption was significantly reduced in MT rats (MT = 47.3 ñ 4.9 vs MC = 99.8 ñ 5.3 nmol min-1 cm-1, Kruskal-Wallis test, P<0.05) but this fact did not hamper the evolution of cancer. There was a significant increase in methionine absorption in both groups (NT = 4.2 ñ 0.3 and MT = 2.0 ñ 0.1 vs NC = 3.7 ñ 0.1 and MC = 1.2 ñ 0.2 nmol min-1 cm-1, Kruskal-Wallis test, P<0.05), whereas leucine absorption was increased only in young tumor-bearing rats (NT = 8.6 ñ 0.2 vs NC = 7.7 ñ 0.4 nmol min-1 cm-1, Kruskal-Wallis test, P<0.05), suggesting that these metabolites are being used for synthesis and oxidation processes by the neoplastic cells, which might ensure their rapid proliferation especially in NT rats.


Subject(s)
Animals , Rats , Carcinoma 256, Walker/metabolism , Glucose/pharmacokinetics , Intestinal Absorption , Leucine/pharmacokinetics , Methionine/pharmacokinetics , Cachexia , Cell Division , Time Factors
17.
Braz J Med Biol Res ; 31(10): 1345-8, 1998 Oct.
Article in English | MEDLINE | ID: mdl-9876308

ABSTRACT

In tumor-bearing rats, most of the serum amino acids are used for synthesis and oxidation processes by the neoplastic tissue. In the present study, the effect of Walker 256 carcinoma growth on the intestinal absorption of leucine, methionine and glucose was investigated in newly weaned and mature rats. Food intake and carcass weight were decreased in newly weaned (NT) and mature (MT) rats bearing Walker 256 tumor in comparison with control animals (NC and MC). The tumor/carcass weight ratio was higher in NT than in MT rats, whereas nitrogen balance was significantly decreased in both as compared to control animals. Glucose absorption was significantly reduced in MT rats (MT = 47.3 +/- 4.9 vs MC = 99.8 +/- 5.3 nmol min-1 cm-1, Kruskal-Wallis test, P < 0.05) but this fact did not hamper the evolution of cancer. There was a significant increase in methionine absorption in both groups (NT = 4.2 +/- 0.3 and MT = 2.0 +/- 0.1 vs NC = 3.7 +/- 0.1 and MC = 1.2 +/- 0.2 nmol min-1 cm-1, Kruskal-Wallis test, P < 0.05), whereas leucine absorption was increased only in young tumor-bearing rats (NT = 8.6 +/- 0.2 vs NC = 7.7 +/- 0.4 nmol min-1 cm-1, Kruskal-Wallis test, P < 0.05), suggesting that these metabolites are being used for synthesis and oxidation processes by the neoplastic cells, which might ensure their rapid proliferation especially in NT rats.


Subject(s)
Carcinoma 256, Walker/physiopathology , Glucose/pharmacokinetics , Intestinal Absorption , Leucine/pharmacokinetics , Methionine/pharmacokinetics , Animals , Cachexia , Cell Division , Rats , Time Factors
18.
Immunol Lett ; 49(3): 163-8, 1996 Mar.
Article in English | MEDLINE | ID: mdl-8739311

ABSTRACT

Several studies in mice have strengthened the active role played either by CD4+, CD8+ or both T cell subsets in conferring resistance to Trypanosoma cruzi infection. To date, no studies reported the role played by T cell subsets on parasite multiplication in different organs. In the present work, mice were infected with CL strain of T. cruzi and T cell subset activities were blocked by i.p. injection of monoclonal antibody (mAb) directed against CD4, or IAk, or CD8 molecules. The effect of these treatments was determined by counting the number of parasite nests in heart and liver sections 16 days after infection. Our results showed that mice treated with anti-CD4 or anti-IAk mAbs presented a significant increase in the parasite load in the hearts and in the livers. Conversely, the number of parasites in hearts of anti-CD8 treated mice did not increase significantly. This treatment, however, resulted in a 20-fold increase in the number of parasites found in the liver. Simultaneous depletion of both T cell subsets by treatment of mice with anti-CD4/CD8 mAbs had, in the heart, the same effect as the CD4 depletion. Interestingly, this treatment caused a dramatic increase (200-fold) in the T. cruzi parasitism of the liver. These results indicate that the activity of T cell subsets against T. cruzi varies according to the infected organ.


Subject(s)
Chagas Disease/immunology , Liver/parasitology , T-Lymphocyte Subsets/immunology , Trypanosoma cruzi/immunology , Animals , Antibodies, Monoclonal/immunology , Antibodies, Protozoan/immunology , Female , Heart/parasitology , Immunity, Cellular , Lymphocyte Depletion , Mice , Mice, Inbred C3H
20.
Vet Hum Toxicol ; 37(3): 217-20, 1995 Jun.
Article in English | MEDLINE | ID: mdl-7571347

ABSTRACT

To evaluate the effectiveness of the treatment of severe ammonia intoxication with amino acids from the urea cycle (arginine, citrulline and ornithine) and alpha-ketoglutarate, 371 rats were used. The rats were poisoned with a lethal ip dose (99.9%) of ammonium acetate. Five min later they were treated with bidistilled water (control) or with standard urea-cycle mixed amino acid solutions containing 2, 4 or 6 mM arginine/kg bw as the marker basic amino acid or 2 mM arginine + 4 mM alpha-ketoglutarate/kg bw. The clinical picture and plasma urea concentration were followed. All 4 treatment groups had higher survival rates (20.83%-35.71%) than did the controls (1.18%). Surviving animals had a less severe clinical picture and presented fewer convulsive episodes than did fatally-poisoned rats. The higher doses of arginine increased the mean survival time of rats which died. The overall mean plasma urea concentration in surviving rats was higher (75.1 +/- 10.8 mg/dL) than in fatally-poisoned rats (44.4 +/- 4.9 mg/dL). Treatment with urea-cycle amino acids increased hepatic detoxication of ammonia; however, there was no relationship between the doses used and survival rates. There was no apparent synergism between urea-cycle amino acids and alpha-ketoglutarate.


Subject(s)
Acetates/toxicity , Arginine/therapeutic use , Citrulline/therapeutic use , Ketoglutaric Acids/therapeutic use , Ornithine/therapeutic use , Urea/blood , Acetates/administration & dosage , Analysis of Variance , Animals , Injections, Intraperitoneal , Ketoglutaric Acids/metabolism , Male , Poisoning/drug therapy , Poisoning/mortality , Rats , Rats, Wistar , Survival Rate
SELECTION OF CITATIONS
SEARCH DETAIL
...